Literature DB >> 668775

Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome.

A P Douglas, R L Savage, M D Rawlins.   

Abstract

The pahrmacokinetics of paracetamol after intravenous and oral administration has been studied in 6 patients with Gilbert's syndrome, and 6 healthy controls. Paracetamol clearance was significantly less in the patients (255 ml/min SE +/- 23 ml/min) than in the normal subjects (352 ml/min SE +/- 40 ml/min). Moreover, whilst paracetamol concentrations declined monoexponentially in the patients, the decline was biexponential in the controls. No difference in the bioavailability of 500 mg paracetamol given orally was observed between the two groups. The results suggest that not only is paracetamol elimination impaired in Gilbert's syndrome, but that its distribution kinetics are also abnormal. Both these findings could be attributed to a decrease in hepatic glucuronyl transferase activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668775     DOI: 10.1007/BF00609984

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Gas-liquid chromatographic estimation of paracetamol.

Authors:  L F Prescott
Journal:  J Pharm Pharmacol       Date:  1971-10       Impact factor: 3.765

2.  Diagnosis of Gilbert's syndrome: role of reduced caloric intake test.

Authors:  D Owens; S Sherlock
Journal:  Br Med J       Date:  1973-09-15

3.  The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome.

Authors:  B F Felsher; D Rickard; A G Redeker
Journal:  N Engl J Med       Date:  1970-07-23       Impact factor: 91.245

4.  Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin.

Authors:  P D Berk; J R Bloomer; R B Howe; N I Berlin
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

5.  Differences in the metabolism of drugs depending upon their routes of administration.

Authors:  C T Dollery; D S Davies; M E Conolly
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

6.  Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome.

Authors:  M Black; B H Billing
Journal:  N Engl J Med       Date:  1969-06-05       Impact factor: 91.245

7.  The metabolism of phenacetin in patients with enal diseas.

Authors:  L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

8.  Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.

Authors:  M D Rawlins; D B Henderson; A R Hijab
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

9.  A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man.

Authors:  A J Cummings; M L King; B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02

10.  Glucuronide formation in patients with constitutional hepatic dysfunction (Gilbert's disease).

Authors:  R SCHMID; L HAMMAKER
Journal:  N Engl J Med       Date:  1959-06-25       Impact factor: 91.245

  10 in total
  12 in total

1.  [Not Available].

Authors:  K Menges
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

Review 2.  Paracetamol.

Authors:  T J Meredith; R Goulding
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

3.  Heterogeneity of paracetamol metabolism in Gilbert's syndrome.

Authors:  A Esteban; M Pérez-Mateo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.441

4.  Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites.

Authors:  R H Rumble; M S Roberts; M J Denton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Reduction of paracetamol and aspirin metabolism during viral hepatitis.

Authors:  C Jorup-Rönström; B Beermann; E Wåhlin-Boll; A Melander; S Britton
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

6.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

Review 7.  Gilbert's syndrome and drug metabolism.

Authors:  A F Macklon; R L Savage; M D Rawlins
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

8.  Lack of effect of valproate on paracetamol (acetaminophen) disposition in epileptic patients.

Authors:  I M Kapetanović; H J Kupferberg; W Theodore; R J Porter
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

9.  Antipyrine clearance in patients with Gilbert's syndrome.

Authors:  T Ishizaki; K Chiba; T Sasaki
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.